nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone furoate—CYP3A4—Thiotepa—sarcoma	0.169	0.202	CbGbCtD
Fluticasone furoate—ABCB1—Dactinomycin—sarcoma	0.136	0.162	CbGbCtD
Fluticasone furoate—ABCB1—Mitoxantrone—sarcoma	0.121	0.145	CbGbCtD
Fluticasone furoate—ABCB1—Vincristine—sarcoma	0.0835	0.0996	CbGbCtD
Fluticasone furoate—ABCB1—Etoposide—sarcoma	0.0765	0.0913	CbGbCtD
Fluticasone furoate—CYP3A4—Mitoxantrone—sarcoma	0.0727	0.0867	CbGbCtD
Fluticasone furoate—ABCB1—Doxorubicin—sarcoma	0.0522	0.0623	CbGbCtD
Fluticasone furoate—CYP3A4—Vincristine—sarcoma	0.05	0.0597	CbGbCtD
Fluticasone furoate—CYP3A4—Etoposide—sarcoma	0.0459	0.0547	CbGbCtD
Fluticasone furoate—CYP3A4—Doxorubicin—sarcoma	0.0313	0.0373	CbGbCtD
Fluticasone furoate—Growth retardation—Thiotepa—sarcoma	0.0119	0.0734	CcSEcCtD
Fluticasone furoate—Growth retardation—Dactinomycin—sarcoma	0.0118	0.0728	CcSEcCtD
Fluticasone furoate—Prolonged menses—Vincristine—sarcoma	0.0114	0.0705	CcSEcCtD
Fluticasone furoate—Blood glucose increased—Mitoxantrone—sarcoma	0.00455	0.0281	CcSEcCtD
Fluticasone furoate—Menorrhagia—Vincristine—sarcoma	0.00323	0.02	CcSEcCtD
Fluticasone furoate—Menorrhagia—Mitoxantrone—sarcoma	0.00315	0.0194	CcSEcCtD
Fluticasone furoate—Cataract—Thiotepa—sarcoma	0.00283	0.0175	CcSEcCtD
Fluticasone furoate—Ulcer—Dactinomycin—sarcoma	0.00283	0.0175	CcSEcCtD
Fluticasone furoate—Ulcer—Mitoxantrone—sarcoma	0.00246	0.0152	CcSEcCtD
Fluticasone furoate—Vaginal moniliasis—Epirubicin—sarcoma	0.00215	0.0133	CcSEcCtD
Fluticasone furoate—Vulvovaginal candidiasis—Epirubicin—sarcoma	0.00206	0.0128	CcSEcCtD
Fluticasone furoate—Ulcer—Etoposide—sarcoma	0.00205	0.0127	CcSEcCtD
Fluticasone furoate—Vaginal moniliasis—Doxorubicin—sarcoma	0.00199	0.0123	CcSEcCtD
Fluticasone furoate—Vulvovaginal mycotic infection—Epirubicin—sarcoma	0.00199	0.0123	CcSEcCtD
Fluticasone furoate—Vulvovaginal candidiasis—Doxorubicin—sarcoma	0.00191	0.0118	CcSEcCtD
Fluticasone furoate—Candida infection—Etoposide—sarcoma	0.00185	0.0114	CcSEcCtD
Fluticasone furoate—Vulvovaginal mycotic infection—Doxorubicin—sarcoma	0.00184	0.0114	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Thiotepa—sarcoma	0.00147	0.00906	CcSEcCtD
Fluticasone furoate—Epistaxis—Thiotepa—sarcoma	0.00142	0.00879	CcSEcCtD
Fluticasone furoate—Pharyngitis—Dactinomycin—sarcoma	0.00133	0.00824	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Thiotepa—sarcoma	0.00133	0.00822	CcSEcCtD
Fluticasone furoate—Dysphonia—Epirubicin—sarcoma	0.00132	0.00815	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Mitoxantrone—sarcoma	0.00127	0.00782	CcSEcCtD
Fluticasone furoate—Eye disorder—Thiotepa—sarcoma	0.00127	0.00782	CcSEcCtD
Fluticasone furoate—Immune system disorder—Thiotepa—sarcoma	0.00122	0.00756	CcSEcCtD
Fluticasone furoate—Dysphonia—Doxorubicin—sarcoma	0.00122	0.00754	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Thiotepa—sarcoma	0.00122	0.00754	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Vincristine—sarcoma	0.00118	0.00729	CcSEcCtD
Fluticasone furoate—Herpes simplex—Epirubicin—sarcoma	0.00118	0.00728	CcSEcCtD
Fluticasone furoate—Pharyngitis—Mitoxantrone—sarcoma	0.00116	0.00717	CcSEcCtD
Fluticasone furoate—Ulcer—Epirubicin—sarcoma	0.00115	0.00709	CcSEcCtD
Fluticasone furoate—Back pain—Thiotepa—sarcoma	0.00114	0.00704	CcSEcCtD
Fluticasone furoate—Atrioventricular block—Epirubicin—sarcoma	0.00112	0.00692	CcSEcCtD
Fluticasone furoate—Herpes simplex—Doxorubicin—sarcoma	0.00109	0.00674	CcSEcCtD
Fluticasone furoate—Agitation—Thiotepa—sarcoma	0.00108	0.00669	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Vincristine—sarcoma	0.00108	0.00669	CcSEcCtD
Fluticasone furoate—Ulcer—Doxorubicin—sarcoma	0.00106	0.00656	CcSEcCtD
Fluticasone furoate—Candida infection—Epirubicin—sarcoma	0.00104	0.0064	CcSEcCtD
Fluticasone furoate—Atrioventricular block—Doxorubicin—sarcoma	0.00104	0.0064	CcSEcCtD
Fluticasone furoate—Cough—Thiotepa—sarcoma	0.00103	0.00636	CcSEcCtD
Fluticasone furoate—Back pain—Vincristine—sarcoma	0.00101	0.00625	CcSEcCtD
Fluticasone furoate—Back pain—Mitoxantrone—sarcoma	0.000985	0.00608	CcSEcCtD
Fluticasone furoate—Agitation—Vincristine—sarcoma	0.00096	0.00593	CcSEcCtD
Fluticasone furoate—Candida infection—Doxorubicin—sarcoma	0.000959	0.00593	CcSEcCtD
Fluticasone furoate—Infection—Thiotepa—sarcoma	0.000956	0.0059	CcSEcCtD
Fluticasone furoate—Infection—Dactinomycin—sarcoma	0.000948	0.00586	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Thiotepa—sarcoma	0.000943	0.00583	CcSEcCtD
Fluticasone furoate—Eye disorder—Etoposide—sarcoma	0.000909	0.00562	CcSEcCtD
Fluticasone furoate—Cough—Mitoxantrone—sarcoma	0.000888	0.00549	CcSEcCtD
Fluticasone furoate—Immune system disorder—Etoposide—sarcoma	0.000878	0.00543	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Etoposide—sarcoma	0.000877	0.00542	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Vincristine—sarcoma	0.000853	0.00527	CcSEcCtD
Fluticasone furoate—Infection—Vincristine—sarcoma	0.000847	0.00524	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Vincristine—sarcoma	0.000837	0.00517	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Mitoxantrone—sarcoma	0.000831	0.00513	CcSEcCtD
Fluticasone furoate—Infection—Mitoxantrone—sarcoma	0.000825	0.0051	CcSEcCtD
Fluticasone furoate—Back pain—Etoposide—sarcoma	0.000819	0.00506	CcSEcCtD
Fluticasone furoate—Migraine—Epirubicin—sarcoma	0.000776	0.00479	CcSEcCtD
Fluticasone furoate—Urticaria—Thiotepa—sarcoma	0.000764	0.00472	CcSEcCtD
Fluticasone furoate—Body temperature increased—Thiotepa—sarcoma	0.00076	0.0047	CcSEcCtD
Fluticasone furoate—Body temperature increased—Dactinomycin—sarcoma	0.000755	0.00466	CcSEcCtD
Fluticasone furoate—Dyspnoea—Mitoxantrone—sarcoma	0.000741	0.00458	CcSEcCtD
Fluticasone furoate—Cough—Etoposide—sarcoma	0.000739	0.00456	CcSEcCtD
Fluticasone furoate—Migraine—Doxorubicin—sarcoma	0.000718	0.00443	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Thiotepa—sarcoma	0.000709	0.00438	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Epirubicin—sarcoma	0.000705	0.00435	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Dactinomycin—sarcoma	0.000703	0.00435	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Etoposide—sarcoma	0.000691	0.00427	CcSEcCtD
Fluticasone furoate—Infection—Etoposide—sarcoma	0.000686	0.00424	CcSEcCtD
Fluticasone furoate—Body temperature increased—Vincristine—sarcoma	0.000674	0.00417	CcSEcCtD
Fluticasone furoate—Urticaria—Mitoxantrone—sarcoma	0.00066	0.00408	CcSEcCtD
Fluticasone furoate—Diarrhoea—Thiotepa—sarcoma	0.000658	0.00407	CcSEcCtD
Fluticasone furoate—Body temperature increased—Mitoxantrone—sarcoma	0.000657	0.00406	CcSEcCtD
Fluticasone furoate—Bronchitis—Epirubicin—sarcoma	0.000655	0.00405	CcSEcCtD
Fluticasone furoate—Diarrhoea—Dactinomycin—sarcoma	0.000653	0.00404	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Doxorubicin—sarcoma	0.000652	0.00403	CcSEcCtD
Fluticasone furoate—Dizziness—Thiotepa—sarcoma	0.000636	0.00393	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Vincristine—sarcoma	0.000628	0.00388	CcSEcCtD
Fluticasone furoate—Dyspnoea—Etoposide—sarcoma	0.000616	0.00381	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Mitoxantrone—sarcoma	0.000612	0.00378	CcSEcCtD
Fluticasone furoate—Rash—Thiotepa—sarcoma	0.000607	0.00375	CcSEcCtD
Fluticasone furoate—Bronchitis—Doxorubicin—sarcoma	0.000606	0.00374	CcSEcCtD
Fluticasone furoate—Dermatitis—Thiotepa—sarcoma	0.000606	0.00374	CcSEcCtD
Fluticasone furoate—Headache—Thiotepa—sarcoma	0.000603	0.00372	CcSEcCtD
Fluticasone furoate—Rash—Dactinomycin—sarcoma	0.000602	0.00372	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Epirubicin—sarcoma	0.00059	0.00365	CcSEcCtD
Fluticasone furoate—Diarrhoea—Vincristine—sarcoma	0.000584	0.00361	CcSEcCtD
Fluticasone furoate—Epistaxis—Epirubicin—sarcoma	0.000573	0.00354	CcSEcCtD
Fluticasone furoate—Nausea—Thiotepa—sarcoma	0.000571	0.00353	CcSEcCtD
Fluticasone furoate—Diarrhoea—Mitoxantrone—sarcoma	0.000568	0.00351	CcSEcCtD
Fluticasone furoate—Nausea—Dactinomycin—sarcoma	0.000567	0.0035	CcSEcCtD
Fluticasone furoate—Dizziness—Vincristine—sarcoma	0.000564	0.00349	CcSEcCtD
Fluticasone furoate—Urticaria—Etoposide—sarcoma	0.000549	0.00339	CcSEcCtD
Fluticasone furoate—Body temperature increased—Etoposide—sarcoma	0.000546	0.00338	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Doxorubicin—sarcoma	0.000546	0.00337	CcSEcCtD
Fluticasone furoate—Pharyngitis—Epirubicin—sarcoma	0.000541	0.00334	CcSEcCtD
Fluticasone furoate—Rash—Vincristine—sarcoma	0.000538	0.00332	CcSEcCtD
Fluticasone furoate—Dermatitis—Vincristine—sarcoma	0.000537	0.00332	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Epirubicin—sarcoma	0.000536	0.00331	CcSEcCtD
Fluticasone furoate—Headache—Vincristine—sarcoma	0.000534	0.0033	CcSEcCtD
Fluticasone furoate—Epistaxis—Doxorubicin—sarcoma	0.00053	0.00327	CcSEcCtD
Fluticasone furoate—Visual impairment—Epirubicin—sarcoma	0.000525	0.00325	CcSEcCtD
Fluticasone furoate—Rash—Mitoxantrone—sarcoma	0.000524	0.00324	CcSEcCtD
Fluticasone furoate—Dermatitis—Mitoxantrone—sarcoma	0.000523	0.00323	CcSEcCtD
Fluticasone furoate—Headache—Mitoxantrone—sarcoma	0.00052	0.00322	CcSEcCtD
Fluticasone furoate—Eye disorder—Epirubicin—sarcoma	0.000509	0.00315	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Etoposide—sarcoma	0.000509	0.00315	CcSEcCtD
Fluticasone furoate—Nausea—Vincristine—sarcoma	0.000507	0.00313	CcSEcCtD
Fluticasone furoate—Pharyngitis—Doxorubicin—sarcoma	0.000501	0.00309	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Doxorubicin—sarcoma	0.000496	0.00306	CcSEcCtD
Fluticasone furoate—Nausea—Mitoxantrone—sarcoma	0.000493	0.00305	CcSEcCtD
Fluticasone furoate—Immune system disorder—Epirubicin—sarcoma	0.000492	0.00304	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Epirubicin—sarcoma	0.000491	0.00304	CcSEcCtD
Fluticasone furoate—Visual impairment—Doxorubicin—sarcoma	0.000486	0.003	CcSEcCtD
Fluticasone furoate—Diarrhoea—Etoposide—sarcoma	0.000473	0.00292	CcSEcCtD
Fluticasone furoate—Eye disorder—Doxorubicin—sarcoma	0.000471	0.00291	CcSEcCtD
Fluticasone furoate—Back pain—Epirubicin—sarcoma	0.000459	0.00284	CcSEcCtD
Fluticasone furoate—Dizziness—Etoposide—sarcoma	0.000457	0.00282	CcSEcCtD
Fluticasone furoate—Immune system disorder—Doxorubicin—sarcoma	0.000456	0.00282	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Doxorubicin—sarcoma	0.000455	0.00281	CcSEcCtD
Fluticasone furoate—Agitation—Epirubicin—sarcoma	0.000436	0.00269	CcSEcCtD
Fluticasone furoate—Rash—Etoposide—sarcoma	0.000436	0.00269	CcSEcCtD
Fluticasone furoate—Dermatitis—Etoposide—sarcoma	0.000435	0.00269	CcSEcCtD
Fluticasone furoate—Headache—Etoposide—sarcoma	0.000433	0.00267	CcSEcCtD
Fluticasone furoate—Back pain—Doxorubicin—sarcoma	0.000425	0.00262	CcSEcCtD
Fluticasone furoate—Palpitations—Epirubicin—sarcoma	0.000419	0.00259	CcSEcCtD
Fluticasone furoate—Cough—Epirubicin—sarcoma	0.000414	0.00256	CcSEcCtD
Fluticasone furoate—Nausea—Etoposide—sarcoma	0.00041	0.00254	CcSEcCtD
Fluticasone furoate—Agitation—Doxorubicin—sarcoma	0.000404	0.00249	CcSEcCtD
Fluticasone furoate—Palpitations—Doxorubicin—sarcoma	0.000388	0.0024	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Epirubicin—sarcoma	0.000387	0.00239	CcSEcCtD
Fluticasone furoate—Infection—Epirubicin—sarcoma	0.000385	0.00238	CcSEcCtD
Fluticasone furoate—Cough—Doxorubicin—sarcoma	0.000383	0.00237	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Epirubicin—sarcoma	0.00038	0.00235	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Doxorubicin—sarcoma	0.000358	0.00221	CcSEcCtD
Fluticasone furoate—Infection—Doxorubicin—sarcoma	0.000356	0.0022	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Doxorubicin—sarcoma	0.000351	0.00217	CcSEcCtD
Fluticasone furoate—Dyspnoea—Epirubicin—sarcoma	0.000345	0.00213	CcSEcCtD
Fluticasone furoate—Dyspnoea—Doxorubicin—sarcoma	0.00032	0.00197	CcSEcCtD
Fluticasone furoate—Urticaria—Epirubicin—sarcoma	0.000308	0.0019	CcSEcCtD
Fluticasone furoate—Body temperature increased—Epirubicin—sarcoma	0.000306	0.00189	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Epirubicin—sarcoma	0.000285	0.00176	CcSEcCtD
Fluticasone furoate—Urticaria—Doxorubicin—sarcoma	0.000285	0.00176	CcSEcCtD
Fluticasone furoate—Body temperature increased—Doxorubicin—sarcoma	0.000283	0.00175	CcSEcCtD
Fluticasone furoate—Diarrhoea—Epirubicin—sarcoma	0.000265	0.00164	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Doxorubicin—sarcoma	0.000264	0.00163	CcSEcCtD
Fluticasone furoate—Dizziness—Epirubicin—sarcoma	0.000256	0.00158	CcSEcCtD
Fluticasone furoate—Diarrhoea—Doxorubicin—sarcoma	0.000245	0.00152	CcSEcCtD
Fluticasone furoate—Rash—Epirubicin—sarcoma	0.000244	0.00151	CcSEcCtD
Fluticasone furoate—Dermatitis—Epirubicin—sarcoma	0.000244	0.00151	CcSEcCtD
Fluticasone furoate—Headache—Epirubicin—sarcoma	0.000243	0.0015	CcSEcCtD
Fluticasone furoate—Dizziness—Doxorubicin—sarcoma	0.000237	0.00146	CcSEcCtD
Fluticasone furoate—Nausea—Epirubicin—sarcoma	0.00023	0.00142	CcSEcCtD
Fluticasone furoate—Rash—Doxorubicin—sarcoma	0.000226	0.0014	CcSEcCtD
Fluticasone furoate—Dermatitis—Doxorubicin—sarcoma	0.000226	0.00139	CcSEcCtD
Fluticasone furoate—Headache—Doxorubicin—sarcoma	0.000225	0.00139	CcSEcCtD
Fluticasone furoate—Nausea—Doxorubicin—sarcoma	0.000213	0.00132	CcSEcCtD
